SMJ Article | Review Article
Elevated Lp(a): Guidance for Identifying and Managing Patients
Key Points Elevated lipoprotein(a) (Lp(a)) is considered an independent and causal risk factor for atherosclerotic cardiovascular disease (ASVCD) and calcific aortic valve disease, affecting approximately 20% of individuals. Lp(a) levels are established in youth and are almost exclusively genetic and minimally affected by nonpharmacologic interventions. Clinicians should suspect elevated Lp(a)...